DISABILITY AFTER STROKE AND ITS IMPACT ON SECONDARY PREVENTION

被引:1
|
作者
WADE, DT
机构
[1] Department of Neurological Disability, Rivermead Rehabilitation Centre, Oxford
关键词
STROKE PREVENTION; DISABILITY; HANDICAP; RISK BENEFIT RATIO;
D O I
10.1159/000108745
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
All aspects of stroke management are best considered within the World Health Organisation's framework of illness, which acknowledges four levels: pathology; impairment; disability, and handicap. Prevention ultimately aims to prevent death and minimise handicap. It may be targetted at pathology, preventing cerebral infarction; impairment, preventing symptoms and signs; disability, minimising dependence, or handicap, maximising freedom within society. The risk of recurrence of symptomatic stroke is relatively low (10%/year) and the reduction in risk achievable is only modest (20% reduction). Consequently, it is always necessary to balance the risks of intervention, and the costs (e.g. in terms of reduced pleasure or increased anxiety) against the potential benefit. In severely dependent people, it is unlikely that intervention is warranted.
引用
收藏
页码:24 / 28
页数:5
相关论文
共 50 条
  • [41] Living Well After Stroke - piloting a stroke secondary prevention group in the community
    Cluckie, G.
    Sibson, R.
    Bresnai, J.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 : S23 - S24
  • [42] Secondary prevention measures after a stroke—should they target stroke or heart disease?
    Pierre Fayad
    Nature Clinical Practice Neurology, 2006, 2 : 646 - 647
  • [43] Secondary prevention measures after a stroke - should they target stroke or heart disease?
    Fayad, Pierre
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (12): : 646 - 647
  • [44] Disability after minor stroke and TIA A secondary analysis of the SOCRATES trial
    Cucchiara, Brett
    George, Donna Kurowski
    Kasner, Scott E.
    Knutsson, Mikael
    Denison, Hans
    Ladenvall, Per
    Amarenco, Pierre
    Johnston, S. Claiborne
    NEUROLOGY, 2019, 93 (07) : E708 - E716
  • [45] Secondary Prevention New Recommendations for the Secondary Prevention of Stroke
    Weimar, C.
    AKTUELLE NEUROLOGIE, 2015, 42 (09) : E117 - E117
  • [46] Statins after stroke: how good are we with secondary prevention?
    Idicula, T.
    Logallo, N.
    Brogger, J.
    Naess, H.
    Thomassen, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 65 - 65
  • [47] Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke
    Ringleb, PA
    Schwark, C
    Schwaninger, M
    Schellinger, PD
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 359 - 367
  • [48] Acute treatment and secondary prevention after stroke in a young adult
    De Leeuw, F. -E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 985 - 985
  • [49] Antiepileptic drugs for the primary and secondary prevention of seizures after stroke
    Sykes, Lucy
    Wood, Emma
    Kwan, Joseph
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (01):
  • [50] The new anticoagulants - their role in secondary prevention of thromboembolism after stroke
    Seiffge, David J.
    Nedeltchev, Krassen
    Lyrer, Philippe A.
    THERAPEUTISCHE UMSCHAU, 2012, 69 (09) : 517 - 522